DR. MONTE F JONES MD NPI 1700829249

NPI Information

  • NPI: 1700829249
  • Provider Name: DR. MONTE F JONES, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4510 MEDICAL CENTER DR
    SUITE 215
    MCKINNEY, TX
    ZIP 75069
  • Phone: (972) 542-8609

Map and Directions

Get Directions

NPI Details

DR. Monte F Jones, MD is a hematology and oncology internal medicine in Mckinney, TX with 36 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Monte F Jones, MD NPI is 1700829249. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: BAYLOR COLLEGE OF MEDICINE
Graduation Year:1990

The provider's business location address is:

4510 MEDICAL CENTER DR
SUITE 215
MCKINNEY, TX
ZIP 75069-650
Phone: (972) 542-8609
Fax: (972) 542-8613

The NPI 1700829249 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Magnesium level (HCPCS:83735)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Nuclear medicine study whole body with ct scan (HCPCS:78816)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Unclassified drugs (HCPCS:J3490)
  • Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev (HCPCS:G6013)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev (HCPCS:G6012)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)

The enumeration date for this NPI number is 6/13/2006 and was last updated on 8/20/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyJ5595TEXASNo
2207RH0003XInternal MedicineHematology & OncologyJ5595TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1136912603MEDICAIDTEXAS
2136912612MEDICAIDTEXAS
3136912605MEDICAIDTEXAS
4136912607MEDICAIDTEXAS
5830006523MEDICARE PINTEXAS
68R1477OTHERTEXASBLUE CROSS OF TX
7136912602MEDICAIDTEXAS
8G30104MEDICARE UPIN
9136912604MEDICAIDTEXAS
1087782KMEDICARE PINTEXAS
11421382YM09MEDICARE PINTEXAS
12136912606MEDICAIDTEXAS
1384W424MEDICARE PINTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.